Arbios Systems, Inc.'s Q4/06 Analyst Review Issued by Scimitar Equity Research, Inc.
April 26 2007 - 10:00AM
PR Newswire (US)
BOSTON, April 26 /PRNewswire/ -- Scimitar Equity Research, Inc.
(Scimitar) today issued a review on Arbios Systems, Inc. (OTC:ABOS)
(BULLETIN BOARD: ABOS) entitled "SEPET(TM) Advances Facilitate a
Financing with New Institutional Investors." Arbios Systems, Inc.
is developing proprietary medical devices and cell- based therapies
to enhance the survival of millions of patients each year who
experience, or are at risk for, life-threatening episodes of liver
failure. The Arbios product candidate portfolio includes the
SEPET(TM) Liver Assist Device, a novel blood purification therapy
that provides enhanced "liver dialysis," and the HepatAssist(TM)
Cell-Based Liver Support System, a bioartificial liver that
combines blood detoxification with liver cell therapy to replace
whole liver function in patients with the most severe forms of
liver failure. The analyst research review is available on
Scimitar's website: http://www.scimitarequity.com/. Scimitar Equity
Research, Inc. provides sponsored equity research of the healthcare
industry for the institutional and investment communities. We
certify that all the views expressed in this review, accurately
reflect our personal views about (OTC:ABOS) (BULLETIN BOARD: ABOS)
and its or their securities. No part of our compensation was, is,
or will be, directly or indirectly, related to the specific
recommendations or views contained in this review and we will not
have any investment banking relationships or personal investment in
any sponsored company. Investors are advised that this analysis and
review is issued solely for informational purposes and is not to be
construed as an offer to sell or the solicitation of an offer to
buy. Scimitar was paid for preparing this review. This analysis and
review does not have regard to the specific investment objectives,
financial situation and the information contained herein is based
on sources that we believe to be reliable but is not guaranteed by
us as being accurate. Any opinions expressed are statements of our
own judgment as of the date of publication and are subject to
change without notice. Please read all our important disclosures.
CONTACT: Scimitar Equity Research, Inc. Henry W. McCusker Director
of Research phone: (617) 559-1080 fax: (617) 559-1083 e-mail:
DATASOURCE: Scimitar Equity Research, Inc. CONTACT: Henry W.
McCusker, Director of Research of Scimitar Equity Research, Inc.,
+1-617-559-1080, Fax: +1-617-559-1083, Web site:
http://www.scimitarequity.com/
Copyright